US5538885AExpiredUtility
Expression systems
Est. expiryDec 21, 2010(expired)· nominal 20-yr term from priority
C12N 2830/85C12N 2830/008C07K 14/805C07K 14/765C07K 14/61C12N 2830/42C07K 14/72C12N 15/85C12N 2840/20C07K 14/47C07K 14/7151C12N 9/20
63
PatentIndex Score
28
Cited by
4
References
6
Claims
Abstract
Expression systems which comprise a mammalian host, such as erythroid cells, transformed with a vector which comprises a promoter, a DNA sequence which codes for a desired polypeptide and a dominant control region. The vectors and methods for preparing polypeptides using the expression systems are also described. In a preferred embodiment, the vector contains cDNA for the desired polypeptide and a sequence which is capable of stabilising mRNA produced from the cDNA. The expression systems are particularly efficient and are capable of secreting the desired polypeptide.
Claims
exact text as granted — not AI-modifiedWe claim:
1. An expression system which comprises murine erythroleukemia cells transformed with a vector which comprises (i) the human beta-globin promoter, (ii) a genomic DNA sequence which codes for a polypeptide heterologous to said murine erythroleukemia cells and (iii) a dominant control region, and wherein after induction of differentiation of said murine erythroleukemia cells, said polypeptide is secreted by said murine erythroleukemia cells.
2. The expression system of claim 1 wherein the dominant control region comprises a micro locus which comprises a 6.5 kb fragment obtained by ligating the fragments: 2.1 kb XbaI - XbaI; 1.9 kb HindIII - HindIII; 1.5 kb KpnI - BgIII; and 1.1 kb partial SacI; from the β-globin gene.
3. A method of preparing a polypeptide, said method comprising cultivating the expression system according to claim 1.
4. An expression system which comprises murine erythroleukemia cells transformed with a vector which comprises (i) the human beta-globin promoter, (ii) the second exon/intron, 3rd exon and polyadenylation sequence, all of the human beta-globin gene, (iii) a cDNA sequence which codes for a polypeptide and (iv) a dominant control region, and wherein after induction of differentiation of said murine erythroleukemia cells, said polypeptide is secreted by said murine erythroleukemia cells.
5. The expression system of claim 4 wherein the dominant control region comprises a micro locus which comprises a 6.5 kb fragment obtained by ligating the fragments: 2.1 kb XbaI - XbaI; 1.9 kb HindIII - HindIII; 1.5 kb KpnI - BgIII ; and 1.1 kb partial SacI; from the β-globin gene.
6. A method of preparing a polypeptide, said method comprising cultivating the expression system according to claim 4.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.